Literature DB >> 9294216

Search for the pathogenesis of the differing phenotype in two compound heterozygote Hungarian brothers with the same genotypic triosephosphate isomerase deficiency.

S Hollán1, M Magócsi, E Fodor, M Horányi, V Harsányi, T Farkas.   

Abstract

In a Hungarian family with triosephosphate isomerase (TPI) deficiency, two compound heterozygote brothers were found with the same severe decrease in TPI activity, but only one of them had the classical symptoms. In search for the pathogenesis of the differing phenotype of the same genotypic TPI deficiency, an increase in red cell membrane fluidity was found. There were roughly 100% and 30% more 16:0/20:4 and 18:0/20:4 diacyl-phosphatidylcholine species in erythrocytes from the two TPI-deficient brothers than in the probes from healthy controls. The activities of acethylcholinesterase and calmodulin induced Ca2+ ATPase were significantly enhanced in erythrocytes from the propositus as compared with those of the neurologically symptom-free brother and other members of the TPI-deficient family as well as to those from healthy controls. Both enzymes are crucially involved in the function of nerve cells. The observed differences in membrane fluidity and enzyme activities between the erythrocytes from the phenotypically differing TPI-deficient brothers underline the importance of investigations into the effect of biophysical changes in the lipid environment of the membrane proteins on the development of disseminated focal neurological disorders of unknown pathogenic origin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9294216      PMCID: PMC23368          DOI: 10.1073/pnas.94.19.10362

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

Review 1.  Calcium pump of the plasma membrane.

Authors:  E Carafoli
Journal:  Physiol Rev       Date:  1991-01       Impact factor: 37.312

2.  Asymmetry of membrane fluidity in the lipid bilayer of blood platelets: fluorescence study with diphenylhexatriene and analogs.

Authors:  S Kitagawa; M Matsubayashi; K Kotani; K Usui; F Kametani
Journal:  J Membr Biol       Date:  1991-02       Impact factor: 1.843

3.  Electrophysiology of pars compacta cells in the in vitro substantia nigra--a possible mechanism for dendritic release.

Authors:  R Llinás; S A Greenfield; H Jahnsen
Journal:  Brain Res       Date:  1984-02-27       Impact factor: 3.252

4.  Ouabain-sensitive interaction between human red cell membrane and glycolytic enzyme complex in cytosol.

Authors:  E T Fossel; A K Solomon
Journal:  Biochim Biophys Acta       Date:  1978-06-16

5.  Unidimensional thin-layer chromatography of phospholipids on boric acid-impregnated plates.

Authors:  J B Fine; H Sprecher
Journal:  J Lipid Res       Date:  1982-05       Impact factor: 5.922

6.  The nervous system has an absolute molecular species requirement for proper function.

Authors:  N Salem; C D Niebylski
Journal:  Mol Membr Biol       Date:  1995 Jan-Mar       Impact factor: 2.857

7.  Erythrocyte lipids in triose-phosphate isomerase deficiency.

Authors:  S Hollán; I Dey; L Szollár; M Horányi; M Magócsi; V Harsányi; T Farkas
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-03       Impact factor: 11.205

8.  Oxytocin pretreatment of pregnant rat uterus inhibits Ca2+ uptake in plasma membrane and sarcoplasmic reticulum.

Authors:  M Magocsi; J T Penniston
Journal:  Biochim Biophys Acta       Date:  1991-03-18

9.  Hereditary triosephosphate isomerase (TPI) deficiency: two severely affected brothers one with and one without neurological symptoms.

Authors:  S Hollán; H Fujii; A Hirono; K Hirono; H Karro; S Miwa; V Harsányi; E Gyódi; M Inselt-Kovács
Journal:  Hum Genet       Date:  1993-11       Impact factor: 4.132

10.  A non-cholinergic function for acetylcholinesterase in the substantia nigra: behavioural evidence.

Authors:  S A Greenfield; I W Chubb; R A Grünewald; Z Henderson; J May; S Portnoy; J Weston; M C Wright
Journal:  Exp Brain Res       Date:  1984       Impact factor: 1.972

View more
  7 in total

1.  Enhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubules.

Authors:  F Orosz; G Wágner; K Liliom; J Kovács; K Baróti; M Horányi; T Farkas; S Hollán; J Ovádi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 2.  Functional aspects of cellular microcompartmentation in the development of neurodegeneration: mutation induced aberrant protein-protein associations.

Authors:  Judit Ovádi; Ferenc Orosz; Susan Hollán
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

3.  Drosophila model of human inherited triosephosphate isomerase deficiency glycolytic enzymopathy.

Authors:  Alicia M Celotto; Adam C Frank; Jacquelyn L Seigle; Michael J Palladino
Journal:  Genetics       Date:  2006-09-15       Impact factor: 4.562

4.  Degradation of functional triose phosphate isomerase protein underlies sugarkill pathology.

Authors:  Jacquelyn L Seigle; Alicia M Celotto; Michael J Palladino
Journal:  Genetics       Date:  2008-05-05       Impact factor: 4.562

Review 5.  Membranes: a meeting point for lipids, proteins and therapies.

Authors:  Pablo V Escribá; José M González-Ros; Félix M Goñi; Paavo K J Kinnunen; Lászlo Vigh; Lissete Sánchez-Magraner; Asia M Fernández; Xavier Busquets; Ibolya Horváth; Gwendolyn Barceló-Coblijn
Journal:  J Cell Mol Med       Date:  2008-02-08       Impact factor: 5.310

6.  Triose phosphate isomerase deficiency is caused by altered dimerization--not catalytic inactivity--of the mutant enzymes.

Authors:  Markus Ralser; Gino Heeren; Michael Breitenbach; Hans Lehrach; Sylvia Krobitsch
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

7.  Structural and Genetic Studies Demonstrate Neurologic Dysfunction in Triosephosphate Isomerase Deficiency Is Associated with Impaired Synaptic Vesicle Dynamics.

Authors:  Bartholomew P Roland; Alison M Zeccola; Samantha B Larsen; Christopher G Amrich; Aaron D Talsma; Kimberly A Stuchul; Annie Heroux; Edwin S Levitan; Andrew P VanDemark; Michael J Palladino
Journal:  PLoS Genet       Date:  2016-03-31       Impact factor: 5.917

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.